"Can Wyeth win back the 40 million Premarin and Prempro users it's lost since 2002 -- along with $1 billion a year in profits -- with a new menopause drug? Or will the once-bitten women who have filed more than 5,000 lawsuits claiming the hormones gave them cancer feel fooled twice?" asks Martha Rosenberg at AlterNet.org, in this look at Wyeth's hope of marketing Pristiq as the first nonhormonal treatment for menopause symptoms. Basically, instead of synthetic hormones, now they're pushing anti-depressants as the ultimate cure for hot flashes.
File this one under, "If at first you don't succeed, try, try again".